by IIF with an antibody against γ-tubulin 24 hrs after transfection with GFP, GFP-AZI, or GFP-OAZ; shown are representative cells expressing GFP, GFP-AZI, or GFP-OAZ, as indicated (bar = 5 µm) above digitally magnified images of the box surrounding the centrosome (bar = 1 µm); GFP, green; γ-tubulin, red; DNA, blue.
Supplemental Figure 3. miR-dependent depletion of OAZ and AZI.
(A and B) miR constructs reduce the AZI protein and the OAZ message by roughly 50%. Cells transfected with lacZ miR GFP , AZI miR GFP , or OAZ miR GFP were treated with 5 µg/ml blasticidin for three days to kill non-transfected cells. (A) The level of AZI protein was determined in pooled drug resistant cells as described in Figure 1 . Numbers below the tubulin loading control indicate the relative normalized AZI levels. (B) The level of the OAZ and GAPDH messages were determined in pooled drug resistant cells by RT-PCR as described in Figure 1 . Numbers below the GAPDH loading control indicate the relative normalized levels of the OAZ message. (C) OAZ miR GFP only partially depletes centrosomal OAZ. HeLa cells transfected with lacZ miR GFP or OAZ miR GFP were arrested in S-phase for 48h and analyzed by IIF with antibodies against OAZ (red) and γ-tubulin (green). Shown at left is a representative pair of OAZ miR ∆12/13 cells with GFP or GFP-OAZ, cells were arrested in S-phase with a 24 hr HU treatment. GFP-OAZ complexes were immunoprecipitated with a mouse antibody against GFP and analyzed by dual channel immunoblotting on the LI-COR Odyssey scanner with the M02 and MDS antibodies against Mps1 (see Fig. 5 for a description of these antibodies) and an antibody against GFP. In the presence of doxycycline (+Dox) untagged Mps1 ∆12/13 (indicated by an arrowhead) is expressed at roughly 50% the level of endogenous full-length Mps1, but Mps1 ∆12/13 is not detectable in uninduced cells (-Dox) (second panel, "WB: M02"). The MDS antibody recognizes fulllength endogenous Mps1 (closed arrow) and a 293-specific Mps1 isoform (open arrow) that migrates faster than full-length Mps1, but does not bind to Mps1 ∆12/13 (MDS; top panel). The same Mps1 isoform binds to GFP-OAZ in both uninduced cells (where Mps1 ∆12/13 is not present) and induced cells, and is recognized by the Mps1 Degradation Signal antibody that binds to the region of Mps1 that is missing in Mps1 ∆12/13 (MDS; top panel). The failure of the MDS antibody to bind to Mps1 ∆12/13 is most notable in the "Merge" panel.
(B-D) GFP-OAZ complexes prepared as described in (A) were analyzed by dual color immunoblotting on the LI-COR Odyssey scanner with the MDS, N1, C-19, and M02 antibodies (see Fig. 5 for a description of these antibodies). All blots were incubated with Alexa680-donkey anti-rabbit and IRDye800-donkey anti-mouse secondary antibodies. Shown are the signals from both the 680 and 800 channels (only immunoprecipitates are shown, see (A) for controls). (B) Shown is a blot incubated with MDS as the only primary antibody followed by both anti-rabbit and anti-mouse secondary antibodies. Asterisks indicate a non-specific band (presumably non-denatured IgG from the immunoprecipitation) generated by IRDye800 anti-mouse. (C) The coprecipitated form of Mps1 is also recognized by N1. (D) The co-precipitated form of Mps1 is additionally recognized by C19 and M02. Although the N1 and M02 signals are weak, the absence of signal from the anti-mouse antibody in panel (A) shows that these signal are due to the presence of the N1 or M02 antibody. Figure 5 . Modulating Antizyme activity does not affect the levels of cyclin D1 or cyclin A2. (A) Overexpression of OAZ or AZI has no detectable effect on Cyclin D1. HeLa cells were transfected with GFP, GFP-OAZ, or GFP-AZI and collected 48 hrs after transfection. Immunoblot was performed on cell lysates using antibodies against GFP, α-tubulin, and cyclin D1. Quantification using the Licor-Odyssey showed no difference in cyclin D1 levels after normalization to α-tubulin. (B) Depletion of OAZ or AZI has no detectable effect on Cyclin A2. HeLa cells were transfected with control (siCon), OAZspecific (siOAZ), or AZI-specific (siAZI) siRNAs, and collected 48 hrs after transfection. Immunoblot was performed on cell lysates using antibodies against α-tubulin and cyclin A2. Quantification using the Licor-Odyssey showed no difference in cyclin A levels after normalization to α-tubulin. Figure 6 . Model for the Control of Mps1 Degradation by Antizyme. OAZ binds to the Mps1 degradation signal (D.S), and the Mps1-OAZ complex is targeted to the proteasome for degradation. Cdk2 phosphorylates Mps1 at T468 within the degradation signal, and we hypothesize that this phosphorylation prevents OAZ from binding to Mps1. We further hypothesize that both the Mps1-OAZ interaction and Mps1 degradation occur at the centrosome. OAZ might prevent both premature initiation of centrosome duplication and centrosome reduplication by removing Mps1 from centrosomes when Cdk2 activity is low. When Cdk2 levels rise, Mps1 is protected from degradation, allowing centrosome duplication to proceed. An as yet unidentified phosphatase (indicated by a question mark) removes T468 phosphorylation, returning Mps1 to a state permissive for OAZ binding. Mps1 is represented by a white rectangle, with a black rectangle representing the Mps1 degradation signal (D.S; amino acids 420-507, encoded by exons 12 and 13 that are missing in Mps1 ∆12/13 ), and a grey rectangle representing the kinase domain. OAZ is represented as a light grey shape that binds to the Mps1 degradation signal.
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